04.28.15
Pacific BioLabs Inc. (PBL), a pharmaceutical and medical device contract research organization, of Michael has appointed Michael Yakes, Ph.D., as vice president of toxicology, responsible for all toxicology, PK/ADME (pharmacokinetics/absorption, distribution, metabolism and excretion), bioassay, and medical device biocompatibility testing.
Yakes has spent 14 years in the pharmaceutical industry, directing pharmacology programs and managing a team of 44 researchers for Exelixis, and was the senior director of translational biology for Cleave Biosciences, overseeing toxicology, DMPK (drug metabolism and pharmacokinetics) and pharmacology studies.
“We are extremely pleased to welcome Mike to PBL,” said President Tom Spalding. “Mike has an outstanding track record in the pharmaceutical industry, and brings fantastic energy and leadership skills to the position. I’m confident that our current clients will enjoy working with Mike, and that his entrepreneurial skills and business acumen will help PBL continue to grow.”
Yakes has spent 14 years in the pharmaceutical industry, directing pharmacology programs and managing a team of 44 researchers for Exelixis, and was the senior director of translational biology for Cleave Biosciences, overseeing toxicology, DMPK (drug metabolism and pharmacokinetics) and pharmacology studies.
“We are extremely pleased to welcome Mike to PBL,” said President Tom Spalding. “Mike has an outstanding track record in the pharmaceutical industry, and brings fantastic energy and leadership skills to the position. I’m confident that our current clients will enjoy working with Mike, and that his entrepreneurial skills and business acumen will help PBL continue to grow.”